๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Liver Metastases
Clinical trial register · China

Liver Metastases Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 6 Shanghai 4 Wuhan 1 Tianjin 1 Beijing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou6 Shanghai4 Wuhan1 Tianjin1 Beijing1
All 8 locations
Target enrolment
to

Liver Metastases trials in China

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma
NCT07824856Nasopharyngeal Carcinoma, Neoplasm Metastasis, Lung Metastases, Liver Metastases
Sun Yat-sen University
Phase 2
138
Guangzhou
2026-10
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
NCT07602504Liver Metastases, Metastases to Liver, Liver Cancer, Neoplasms
Anhui Provincial Hospital
Observational
2,000
Bengbu, Hefei, Qingdao
2026-06-01
Not yet open
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
NCT07448376CTCs, Pancreatic Cancer, Liver Metastases, Relapse
Huazhong University of Science and Technology
Observational
20
Wuhan
2026-03-01
Recruiting
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
NCT06794086Colorectal Cancer, Liver Metastases
Jun Huang
Phase 3
24
Guangzhou
2025-04-10
Not yet open
Prospective Observational Cohort Study
NCT06493448Gastric Cancer, Liver Metastases
Lin Chen
Observational
1,326
Beijing
2024-07-15
Recruiting
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
NCT06280495Colorectal Cancer, Liver Metastases
Sun Yat-sen University
Phase 2/3
156
Guangzhou
2024-02-01
Not yet open
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
NCT05354674Colorectal Cancer, Liver Metastases
Fudan University
Observational
302
Shanghai
2023-09-01
Not yet open
Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidedness
NCT05881746Colorectal Carcinoma, Liver Metastases
Fudan University
Not applicable
176
Shanghai
2023-07-01
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
490
Guangzhou
2023-02-20
Recruiting
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Cancer, Therapy-Related
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
346
Guangzhou
2023-02-20
Recruiting
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
NCT05057052Liver Metastases, Colorectal Cancer Metastatic
Fudan University
Phase 2
25
Shanghai
2021-09-26
Recruiting
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
NCT04687631Colorectal Cancer, Liver Metastases
Fudan University
Phase 3
508
Shanghai
2021-01-14
Recruiting
TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NCT06487663Hepatocellular Carcinoma Non-resectable, Cholangiocarcinoma Non-resectable, Liver Metastases, Liver Malignant Tumors
Tianjin Medical University Cancer Institute and Hospital
Not applicable
40
Tianjin
2020-10-27
Active, closed
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
NCT03493048Colorectal Cancer, Liver Metastases
Sun Yat-sen University
Phase 2
146
Guangzhou
2018-04-15
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/liver-metastases

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Liver Metastases.

How many Liver Metastases trials are recruiting in China?

8 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liver Metastases), 14 studies
PhaseStudiesRecruitingShare
Observational4128.6%
Phase 34428.6%
Phase 23121.4%
Not applicable2114.3%
Phase 2/3117.1%

Most active sponsors

Lead sponsors with the most studies (Liver Metastases)
Lead sponsorStudiesRecruiting
Fudan University42
Sun Yat-sen University31
Sixth Affiliated Hospital, Sun Yat-sen University22
Anhui Provincial Hospital11
Huazhong University of Science and Technology10
Jun Huang11
Lin Chen10
Tianjin Medical University Cancer Institute and Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.